Novel inhibitor insights offer pathway to preventing PXR-associated drug resistance (IMAGE)
Caption
Corresponding author Taosheng Chen, PhD (left), co-first author Sergio Chai, PhD (center) and co-author Shyaron Poudel, St. Jude Department of Chemical Biology & Therapeutics investigated the inhibitor/activator binding mechanisms of pregnane X receptor (PXR), a protein implicated in drug metabolism.
Credit
St. Jude Children's Research Hospital
Usage Restrictions
No cropping
License
Original content